Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals

Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals

Despite over 13 billion SARS-CoV-2 vaccine doses administered globally, persistent post-vaccination symptoms, termed post-COVID-19 vaccine syndrome (PCVS), resemble post-acute sequelae of COVID-19 (PASC). Symptoms like cardiac, vascular, and neurological issues often emerge shortly after vaccination...

Full description

Saved in:
Bibliographic Details
Main Authors: Bruce K. Patterson, Ram Yogendra, Edgar B. Francisco, Jose Guevara-Coto, Emily Long, Amruta Pise, Eric Osgood, John Bream, Mark Kreimer, Devon Jeffers, Christopher Beaty, Richard Vander Heide, Rodrigo A. Mora-Rodríguez
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
COVID-19
PASC
SARS CoV-2 S1 protein
non-classical monocytes
CCR5
fractalkine
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2494934
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2025.2494934

Similar Items